You are here

• Home
• About AstraZeneca US
• Newsroom

• Product news

The following shows headlines of all product-related news articles published within 12-months, starting from most recent.

• Pages
• 1
• 2
• 3
• Next

• • Dec 5, 2011
  • Despite trend of therapeutic substitution, survey data shows patients want their physician to be the ultimate decision maker on their Rx medications  
• • Nov 15, 2011
  • SATURN demonstrated effect of intensive statin treatment on reducing atherosclerosis  
• • Nov 7, 2011
  • BRILINTA™ (ticagrelor) receives additional Class I recommendation in new U.S. Guidelines from ACCF/AHA/SCAI for PCI  
• • Nov 7, 2011
  • New CRESTOR® (rosuvastatin calcium) Savings Card Program provides instant savings to patients  
• • Nov 3, 2011
  • BRILINTA™ (ticagrelor) receives Class I recommendation in new US Guidelines from the American College of Cardiology Foundation and the American Heart Association  
• • Oct 5, 2011
  • AstraZeneca enters into a settlement agreement with Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd regarding U.S. SEROQUEL XR® patent litigation  
• • Sep 29, 2011
  • AstraZeneca enters into a settlement agreement with Handa Pharmaceuticals regarding U.S. SEROQUEL XR® patent litigation  
• • Sep 1, 2011
  • New survey shows only one-third of Americans know their cholesterol levels  
• • Aug 25, 2011
  • NEXIUM® (esomeprazole magnesium) launches new savings card offering instant discounts for patients  
• • Aug 22, 2011
  • BRILINTA™ (ticagrelor) tablets now available in U.S. pharmacies for patients with acute coronary syndrome  

• Pages
• 1
• 2
• 3
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed